News & Publications2024-12-16T11:08:46+00:00

NEWS

PUBLICATIONS

  • Using immuno-PET imaging to monitor kinetics of T cell-mediated inflammation and treatment efficiency in a humanized mouse model for GvHD. Eur J Nucl Med Mol Imaging. [Pektor S, Schlöder J, Klasen B, Bausbacher N, Wagner DC, Schreckenberger M, Grabbe S, Jonuleit H, Miederer M.]
  • Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. International Journal of Molecular Sciences. [Schlöder J, Berges C, Luessi F, Jonuleit H.]
  • Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host Disease. Front Immunol. [Schlöder J, Berges C, Tuettenberg A, Jonuleit H.]
  • Editorial: Current Concepts of Cellular and Biological Drugs to Modulate Regulatory T Cell Activity in the Clinic. Front Immunol. [Jonuleit H, Bopp T.]
  • Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network. PLoS One. [Tuettenberg A, Hahn SA, Mazur J, Gerhold-Ay A, Scholma J, Marg I, Ulges A, Satoh K, Bopp T, Joore J, Jonuleit H.]
  • Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells. Int J Mol Sci. [Trinschek B, Luessi F, Gross CC, Wiendl H, Jonuleit H.]
  •  Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis. PLoS ONE. [Trinschek B, Luessi F, Haas J, Wildemann B, Zipp F, et al.]
  • In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling. Sci Transl Med. [Schneider A, Long SA, Cerosaletti K, Ni CT, Samuels P, Kita M, Buckner JH.]
  • Boosting regulatory T cell function by CD4 stimulation enters the clinic. Front Immunol. [Becker C, Bopp T, Jonuleit H.]
  • CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease. J Allergy Clin Immunol. [Martin H, Reuter S, Dehzad N, Heinz A, Bellinghausen I, Saloga J, Haasler I, Korn S, Jonuleit H, Buhl R, Becker C, Taube C.]
  • Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. Blood. [Becker C, Taube C, Bopp T, Becker C, Michel K, Kubach J, Reuter S, Dehzad N, Neurath MF, Reifenberg K, Schneider FJ, Schmitt E, Jonuleit H.]
Nach oben